Sickle cell disease in Africa
Sickle cell disease in Africa
复制标题
DOI：
10.1097/00062752-200203000-00005
复制
发表时间：
2002-03-01
影响因子：
3.2
通讯作者：
Tchernia, G
中科院分区：
文献类型：
--
作者：
Diallo, D;Tchernia, G
非洲是镰状细胞突变的主要发源地;每年受镰状细胞病影响的新生儿人数估计为20万。然而，由于家庭收入和公共卫生资金低，以及在较小程度上由于当地对镰状细胞病的看法，对病人的总体治疗仍然很差，在一些地方，治疗不足。努力适应治疗方案和克服困难的介绍和分析。Curr Opin Hematol 2002，9：111-116（C）2002 Lippincott威廉姆斯威尔金斯公司
Africa is the main birthplace of sickle mutations; the number of newborns affected by sickle cell disease is estimated at 200,000 per year. However, because of low family income and public health funding and, to a lesser extent, because of local beliefs about sickle cell disease, overall treatment of patients is still poor and, in some places, inadequate. Efforts to adapt therapeutic options and overcome difficulties are presented and analyzed. Curr Opin Hematol 2002, 9:111-116 (C) 2002 Lippincott Williams Wilkins, Inc.